Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes

Kfir Sharabi, Hua Lin, Clint D.J. Tavares, John E. Dominy, Joao Paulo Camporez, Rachel J. Perry, Roger Schilling, Amy K. Rines, Jaemin Lee, Marc Hickey, Melissa Bennion, Michelle Palmer, Partha P. Nag, Joshua A. Bittker, José Perez, Mark P. Jedrychowski, Umut Ozcan, Steve P. Gygi, Theodore M. Kamenecka, Gerald I. ShulmanStuart L. Schreiber, Patrick R. Griffin, Pere Puigserver*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

157 Scopus citations

Fingerprint

Dive into the research topics of 'Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science